Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological response modifiers in cancer therapy.

Shalini Gupta1, Avinash K Kanodia

  • 1Lady Hardinge Medical College, New Delhi, India. shalini_19gupta@rediffmail.com

The National Medical Journal of India
|September 26, 2002
PubMed
Summary

Biological response modifiers, including monoclonal antibodies and anticancer vaccines, harness the immune system to fight cancer. Ongoing research refines these immunostimulatory agents for improved cancer treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Rapid pan-cancer detection <i>via</i> label-free impedance profiling of cell-free DNA.

Lab on a chip·2026
Same author

Premenstrual syndrome and its relation to socio demographic variables among middle -aged women in India.

Bioinformation·2026
Same author

Panoramic Insights: Predicting Age and Gender from Dental X-Rays Using Deep Learning Models.

Journal of imaging informatics in medicine·2026
Same author

Evaluation of large language models with clinical guidance for vetting outpatient magnetic resonance imaging lumbar spine referrals.

Scottish medical journal·2026
Same author

Role of Dexmedetomidine on Hemodynamics and Anesthetic Requirement in Patients Undergoing Elective Infratentorial Tumor Surgery: A Prospective, Randomized, Double-blind, Placebo-controlled Study.

Annals of African medicine·2026
Same author

Ovarian Rev-erbα: a central regulator of fertility following chronodisruption.

Frontiers in endocrinology·2026

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Biological response modifiers (BRMs) leverage immunostimulation to enhance the body's anti-cancer defenses.
  • Scientific application of BRMs has significantly advanced in the last decade due to progress in tumor immunology.

Purpose of the Study:

  • To review the current landscape and applications of various biological response modifiers in cancer treatment.
  • To highlight recent advancements and ongoing investigations into novel BRM development.

Main Methods:

  • Review of approved and investigational biological response modifiers.
  • Categorization of BRMs including monoclonal antibodies, interferons, interleukins, and vaccines.
  • Discussion of specific agents and their therapeutic targets and applications in various cancers.

Main Results:

  • Monoclonal antibodies (e.g., trastuzumab, rituximab) are approved for treating specific cancers like breast cancer and non-Hodgkin's lymphoma.
  • Interferons and Interleukin-2 show efficacy in treating certain leukemias, Kaposi's sarcoma, renal cell carcinoma, and malignant melanoma.
  • Colony-stimulating factors support bone marrow function during chemotherapy, while thalidomide exhibits anti-angiogenic properties.

Conclusions:

  • Biological response modifiers represent a significant advancement in cancer therapy, offering targeted approaches.
  • Development of novel anticancer vaccines and DNA-based vaccination strategies are under active investigation.
  • Further research is needed to optimize antigen selection, delivery vectors, and administration regimens for various BRMs.

Related Experiment Videos